It has been reported that COPS5 plays a crucial role in tamoxifen resistance in oestrogen receptor α (ERα) positive breast cancer patients, through regulating NCoR ubiquitination-proteasomal degradation. This evidence concerns the gene NCOR1 and breast cancer.